124 related articles for article (PubMed ID: 27416002)
21. Circulating levels of plasminogen and oxidized phospholipids bound to plasminogen distinguish between atherothrombotic and non-atherothrombotic myocardial infarction.
DeFilippis AP; Chernyavskiy I; Amraotkar AR; Trainor PJ; Kothari S; Ismail I; Hargis CW; Korley FK; Leibundgut G; Tsimikas S; Rai SN; Bhatnagar A
J Thromb Thrombolysis; 2016 Jul; 42(1):61-76. PubMed ID: 26510751
[TBL] [Abstract][Full Text] [Related]
22. Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study.
Tsimikas S; Kiechl S; Willeit J; Mayr M; Miller ER; Kronenberg F; Xu Q; Bergmark C; Weger S; Oberhollenzer F; Witztum JL
J Am Coll Cardiol; 2006 Jun; 47(11):2219-28. PubMed ID: 16750687
[TBL] [Abstract][Full Text] [Related]
23. Measurement of oxidized lipoprotein (a) in patients with acute coronary syndromes and stable coronary artery disease by 2 ELISAs: using different capture antibody against oxidized lipoprotein (a) or oxidized LDL.
Wang JJ; Han AZ; Meng Y; Gong JB; Zhang CN; Li K; Liu YX
Clin Biochem; 2010 Apr; 43(6):571-5. PubMed ID: 20060390
[TBL] [Abstract][Full Text] [Related]
24. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
[TBL] [Abstract][Full Text] [Related]
25. Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin.
Rodenburg J; Vissers MN; Wiegman A; Miller ER; Ridker PM; Witztum JL; Kastelein JJ; Tsimikas S
J Am Coll Cardiol; 2006 May; 47(9):1803-10. PubMed ID: 16682304
[TBL] [Abstract][Full Text] [Related]
26. Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial.
Byun YS; Lee JH; Arsenault BJ; Yang X; Bao W; DeMicco D; Laskey R; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2015 Apr; 65(13):1286-1295. PubMed ID: 25835440
[TBL] [Abstract][Full Text] [Related]
27. Oxidized phospholipids are present on plasminogen, affect fibrinolysis, and increase following acute myocardial infarction.
Leibundgut G; Arai K; Orsoni A; Yin H; Scipione C; Miller ER; Koschinsky ML; Chapman MJ; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2012 Apr; 59(16):1426-37. PubMed ID: 22497821
[TBL] [Abstract][Full Text] [Related]
28. Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a).
Krychtiuk KA; Kastl SP; Hofbauer SL; Wonnerth A; Goliasch G; Ozsvar-Kozma M; Katsaros KM; Maurer G; Huber K; Dostal E; Binder CJ; Pfaffenberger S; Oravec S; Wojta J; Speidl WS
J Clin Lipidol; 2015; 9(4):533-41. PubMed ID: 26228671
[TBL] [Abstract][Full Text] [Related]
29. A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow-Fed Young Adult Mice.
Palmieri M; Kim HN; Gomez-Acevedo H; Que X; Tsimikas S; Jilka RL; Manolagas SC; Witztum JL; Ambrogini E
J Bone Miner Res; 2021 Jan; 36(1):170-185. PubMed ID: 32990984
[TBL] [Abstract][Full Text] [Related]
30. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against human oxidized low-density lipoprotein (LDL) as markers for human plasma modified lipoproteins.
Radulescu L; Stancu C; Antohe F
Med Sci Monit; 2004 Jul; 10(7):BR207-14. PubMed ID: 15232494
[TBL] [Abstract][Full Text] [Related]
32. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
[TBL] [Abstract][Full Text] [Related]
33. Lipoprotein(A) with An Intact Lysine Binding Site Protects the Retina From an Age-Related Macular Degeneration Phenotype in Mice (An American Ophthalmological Society Thesis).
Handa JT; Tagami M; Ebrahimi K; Leibundgut G; Janiak A; Witztum JL; Tsimikas S
Trans Am Ophthalmol Soc; 2015; 113():T5. PubMed ID: 26538774
[TBL] [Abstract][Full Text] [Related]
34. Plasma level of oxidized low-density lipoprotein is an independent determinant of coronary macrovasomotor and microvasomotor responses induced by bradykinin.
Matsumoto T; Takashima H; Ohira N; Tarutani Y; Yasuda Y; Yamane T; Matsuo S; Horie M
J Am Coll Cardiol; 2004 Jul; 44(2):451-7. PubMed ID: 15261947
[TBL] [Abstract][Full Text] [Related]
35. The role of phospholipid oxidation products in inflammatory and autoimmune diseases: evidence from animal models and in humans.
Leitinger N
Subcell Biochem; 2008; 49():325-50. PubMed ID: 18751917
[TBL] [Abstract][Full Text] [Related]
36. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
[TBL] [Abstract][Full Text] [Related]
37. The I4399M variant of apolipoprotein(a) is associated with increased oxidized phospholipids on apolipoprotein B-100 particles.
Arai K; Luke MM; Koschinsky ML; Miller ER; Pullinger CR; Witztum JL; Kane JP; Tsimikas S
Atherosclerosis; 2010 Apr; 209(2):498-503. PubMed ID: 19880117
[TBL] [Abstract][Full Text] [Related]
38. Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
Clarke R; Hammami I; Sherliker P; Valdes-Marquez E; Watkins H; Hill M; Yang X; Tsimikas S; Hopewell JC;
Atherosclerosis; 2022 Aug; 354():15-22. PubMed ID: 35803063
[TBL] [Abstract][Full Text] [Related]
39. Role of protein kinase C δ in apoptotic signaling of oxidized phospholipids in RAW 264.7 macrophages.
Vogl F; Humpolícková J; Amaro M; Koller D; Köfeler H; Zenzmaier E; Hof M; Hermetter A
Biochim Biophys Acta; 2016 Apr; 1861(4):320-30. PubMed ID: 26707247
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B-bound lipids as a marker for evaluation of low density lipoprotein oxidation in vivo.
Tertov VV; Kaplun VV; Dvoryantsev SN; Orekhov AN
Biochem Biophys Res Commun; 1995 Sep; 214(2):608-13. PubMed ID: 7677772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]